Suppression of transforming growth factor-β by mesenchymal stem-cells accelerates liver regeneration in liver fibrosis animal model
Open Access
- 2 January 2021
- journal article
- research article
- Published by Universa Medicina in Universa Medicina
- Vol. 40 (1), 29-35
- https://doi.org/10.18051/univmed.2021.v40.29-35
Abstract
Introduction Liver fibrosis (LF) results from the unregulated chronic wound healing process in liver tissue. Transforming growth factor-beta (TGF-β) is the major contributing cytokine of LF promotion through activation of quiescent hepatic stellate cells (HSCs) into myofibroblasts (MFs) and increased extracellular matrix (ECM) deposition such as collagen leading to scar tissue development. Mesenchymal stem cells (MSCs) have an immunomodulatory capability that could be used as a new treatment for repairing and regenerating LF through suppression of TGF-β. This study aimed to examine the role of MSCs in liver fibrosis animal models through suppression of TGF-β levels without scar formation particularly in the proliferation phase. Methods In this study, a completely randomized design was used with sample size of 24. Male Sprague Dawley rats were injected intraperitoneally (IP) with carbon tetrachloride (CCl4), twice weekly, for eight weeks to induce LF. Rats were randomly assigned to four groups: negative control, CCl4 group, and CCL4 + MSC-treated groups T1 and T2, at doses of 1 x 106 and 2x106 cells, respectively. TGF-β levels were analyzed by enzyme-linked immunosorbent assay (ELISA). One-way ANOVA and a least significant difference (LSD) was used to analyse the data. Results The TGF levels of LF rat models decreased on day 7 after MSC administration. The levels of TGF-β in both MSC groups T1 and T2 decreased significantly compared with the control group (p<0.05). The TGF-β suppression capability of T2 was optimal and more significant than that of T1. Conclusion MSCs can suppress TGF levels in liver fibrosis induced rats.Keywords
This publication has 25 references indexed in Scilit:
- Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and HepatocarcinogenesisFrontiers in Oncology, 2018
- Mesenchymal Stem Cells in Fibrotic DiseaseCell Stem Cell, 2017
- TGF-β1 Signaling and Tissue FibrosisCold Spring Harbor Perspectives in Biology, 2017
- Mesenchymal stromal cells and liver fibrosis: a complicated relationshipThe FASEB Journal, 2016
- New Developments on the Treatment of Liver FibrosisDigestive Diseases, 2016
- TGF-β/SMAD Pathway and Its Regulation in Hepatic FibrosisJournal of Histochemistry & Cytochemistry, 2016
- Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine FamilyMediators of Inflammation, 2015
- Mesenchymal stem cells ameliorate diabetic glomerular fibrosis in vivo and in vitro by inhibiting TGF-β signalling via secretion of bone morphogenetic protein 7Diabetes and Vascular Disease Research, 2014
- NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responsesRedox Biology, 2014
- Liver precursor cells increase hepatic fibrosis induced by chronic carbon tetrachloride intoxication in ratsLaboratory Investigation, 2012